scholarly journals Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients

2007 ◽  
Vol 13 (12) ◽  
pp. 1743-1750 ◽  
Author(s):  
Alan Reed ◽  
Jill Boylston Herndon ◽  
Nail Ersoz ◽  
Takahisa Fujikawa ◽  
Denise Schain ◽  
...  
Keyword(s):  
High Risk ◽  
Liver Transplant ◽  
Fungal Infection ◽  
Transplant Recipients ◽  
Liver Transplant Recipients

scholarly journals Randomized Trial of Micafungin for the Prevention of Invasive Fungal Infection in High-Risk Liver Transplant Recipients

2014 ◽  
Vol 60 (7) ◽  
pp. 997-1006 ◽  
Author(s):  
Faouzi Saliba ◽  
Andreas Pascher ◽  
Olivier Cointault ◽  
Pierre-François Laterre ◽  
Carlos Cervera ◽  
...  
Keyword(s):  
High Risk ◽  
Liver Transplant ◽  
Fungal Infection ◽  
Randomized Trial ◽  
Invasive Fungal Infection ◽  
Transplant Recipients ◽  
Liver Transplant Recipients

Comparison between kidney and liver transplant recipients admitted to a referral center regarding coronavirus-2019 manifestations in the Northeast of Iran during three peaks of pandemic

2021 ◽  
Vol 17 ◽  
Author(s):  
Mohsen Aliakbarian ◽  
Rozita Khodashahi ◽  
Mahin Ghorban Sabbagh ◽  
Hamid Reza Naderi ◽  
Mandana Khodashahi ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
High Risk ◽  
Liver Transplant ◽  
Severe Infection ◽  
Clinical Findings ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Cross Sectional ◽  
Significant Difference ◽  
Liver Transplant Recipients

Background: Transplant recipients are at high risk for severe Coronavirus disease-2019 (COVID-19). Transplant recipients are immune-compromised individuals at high risk for severe infection. This study aimed to compare the presentations and outcomes of liver and kidney transplant recipients who were infected with COVID-19 in the Iranian population. Methods: This cross-sectional study was conducted at Imam Reza and Montaserieh Hospitals affiliated with Mashhad University of Medical Sciences, Mashhad, Iran, between 2020 and 2021. In general, 52 patients were selected and divided into two groups of the kidney (n=28) and liver (n=24) transplantation. Two groups were compared in terms of demographic characteristics and clinical findings. Results: Of 52 patients, severe COVID-19 infection was reported in 61% of the patients. There was no significant difference between the two groups in terms of symptoms, except for cough (χ2=8.09; P=0.004), clinical condition, and laboratory symptoms, except for creatinine (Z=14; P<0.005), alkaline phosphatase (Z=4.55; P=0.03), total bilirubin (Z=8.93; P=0.03), and partial thromboplastin time (Z=5.97; P=0.01). There was no relationship between the outcome and the use of immunosuppressive medications (P>0.05). All patients with kidney transplantation survived, while two cases in the liver transplantation group failed to survive (χ2=2.42; P=0.11). Conclusion: The mortality rate was higher in the liver transplant recipients, compared to the patients who underwent kidney transplantation.

Prophylactic antiviral therapy in CMV high-risk liver transplant recipients

2001 ◽  
Vol 33 (1-2) ◽  
pp. 1811-1812 ◽  
Author(s):  
J.M Rabkin ◽  
H.R Rosen ◽  
C.L Corless ◽  
S.L Orloff ◽  
A.J Olyaei
Keyword(s):  
High Risk ◽  
Liver Transplant ◽  
Antiviral Therapy ◽  
Transplant Recipients ◽  
Prophylactic Antiviral Therapy ◽  
Liver Transplant Recipients

scholarly journals Association of hepatic iron overload with invasive fungal infection in liver transplant recipients

2006 ◽  
Vol 12 (12) ◽  
pp. 1799-1804 ◽  
Author(s):  
Jacob Alexander ◽  
Ajit P. Limaye ◽  
Cynthia W. Ko ◽  
Mary P. Bronner ◽  
Kris V. Kowdley
Keyword(s):  
Iron Overload ◽  
Liver Transplant ◽  
Fungal Infection ◽  
Invasive Fungal Infection ◽  
Hepatic Iron ◽  
Transplant Recipients ◽  
Hepatic Iron Overload ◽  
Liver Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document